)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Fagron (FAGR) investor relations material
Fagron Q3 2025 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 TU earnings summary9 Oct, 2025
Executive summary
Q3 2025 revenue grew 6.4% year-over-year to €228.2 million, with normalized organic growth of 8.5% and 5.7% organic growth at constant rates, excluding GLP-1s.
Eight acquisitions completed year-to-date, including University Compounding Pharmacy in North America and UCP in California, with integrations progressing well and a strong M&A pipeline.
FDA verified corrective and preventive actions at Wichita, validated capacity expansion, and issued Form 483s with several observations at Wichita and Anazao, with no repeat issues.
Financial highlights
Q3 2025 total revenue reached €228.2 million, up 6.4% year-over-year; 9M 2025 revenue at €704.4 million, up 9.4%.
EMEA revenue up 17.3% year-over-year in Q3 2025, with strong growth across all segments.
Latin America revenue increased 9.2% year-over-year, with Brands segment up 21.5%.
North America revenue declined 3.1% year-over-year, reflecting absence of GLP-1 drug shortages and lower productivity due to facility validation.
Wichita facility capacity expansion validated by FDA, expected to generate $25 million in additional revenue.
Outlook and guidance
Full-year 2025 revenue guidance confirmed at €930–€950 million, with a slight year-on-year profitability increase expected.
CapEx expected to remain around 3.5% of revenues, excluding announced one-off projects.
Expansion CapEx includes $39 million for Wichita, $29 million for Las Vegas, and €15 million for a sterile facility in the Netherlands.
Guidance excludes signed acquisitions not yet closed and assumes stable market conditions.
Address new FDA 483 observations at Wichita/Anazao
Timeline for $25M NA capacity expansion revenue?
Quantify M&A contribution to growth/profitability
Purifarma's impact on US product cost pricing?
Reconcile Wichita's 483 with no repeat observations.
GLP-1 compounding: competitive landscape outlook?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Fagron earnings date
H2 202512 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Fagron NV is a multinational company that operates within the healthcare sector, specializing in the provision of products and services for pharmaceutical compounding. It supplies a wide range of products, including raw materials, flammable products, extracts and tinctures, anesthetics, syrups, ointment bases, medispend, triturations, suspension media, phyto pharmaflore, capsicards systems, and consumables. These offerings support the customized preparation of medications to meet specific patient needs, catering to various applications such as allergy, skin care, and hemorrhoids. The company's operations span across Europe, the United States, Brazil, and Argentina, divided into four main segments: Fagron Specialty Pharma Services, Fagron Trademarks, Fagron Essentials, and HL Technology. The company is headquartered in Nazareth, Belgium, and its shares are listed on the Euronext Brussels.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage